Abstract
Background
We determined the usefulness and prognostic ability of the renal risk score (RRS), proposed in Europe, for Japanese patients with antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis (AAGN) and high myeloperoxidase (MPO)-ANCA positivity; these aspects remain to be verified.
Methods
This retrospective study was conducted on 86 Japanese patients with new, biopsy-confirmed AAGN. We calculated the RRS and analyzed the relationship between this classification, and clinicopathological features and prognosis. We also compared the predictive values between RRS for endpoints including renal death and conventional prognostic tools for patients with AAGN.
Results
There were 33, 37, and 16 patients in the low-, medium-, and high-risk groups, respectively. All patients were MPO-ANCA positive. The median follow-up period was 33 months; 16 (18.6%) patients progressed to end-stage renal disease (ESRD). In the high-risk group, 9/16 (56.3%) patients progressed to ESRD, and renal prognosis was significantly poorer than that in other groups (low-risk group, P < 0.001; medium-risk group, P = 0.004). In Cox multivariate regression analysis, RRS was an independent, poor renal prognostic factor (hazard ratio 5.22; 95% confidence interval 2.20–12.40; P < 0.001). The receiver-operating characteristic curves of the RRS for each endpoint were comparable with those of the 2010 histological classification and those of the severity classification of Japanese rapidly progressive glomerulonephritis.
Conclusions
This is the first study to report the usefulness of the RRS for predicting renal outcomes among Japanese patients with AAGN. Our predictive value of the RRS was comparable with that of conventional prognostic tools.
Similar content being viewed by others
References
Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013;65:1–11.
Furuta S, Jayne DRW. Antineutrophil cytoplasm antibody-associated vasculitis: recent developments. Kidney Int. 2013;84:244–9.
Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, et al. Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol. 2010;21:1628–36.
Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, et al. A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol. 2009;13:633–50.
Brix SR, Noriega M, Tennstedt P, Vettorazzi E, Busch M, Nitschke M, et al. Development and validation of a renal risk score in ANCA-associated glomerulonephritis. Kidney Int. 2018;94:1177–88.
Watts RA, Scott DGI, Jayne DRW, Ito-Ihara T, Muso E, Fujimoto S, et al. Renal vasculitis in Japan and the UK-are there differences in epidemiology and clinical phenotype? Nephrol Dial Transplant. 2008;23:3928–31.
Hiromura K, Ikeuchi H, Kayakabe K, Sugiyama H, Nagata M, Sato H, et al. Clinical and histological features of lupus nephritis in Japan: a cross-sectional analysis of the Japan Renal Biopsy Registry (J-RBR). Nephrology (Carlton). 2017;22:885–91.
Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
Ozaki S. ANCA-associated vasculitis: diagnostic and therapeutic strategy. Allergol Int. 2007;56:87–96.
Mukhtyar C, Lee R, Brown D, Carruthers D, Dasgupta B, Dubey S, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis. 2009;68:1827–32.
Saito A, Komatsuda A, Saito M, Kaga H, Abe F, Sawamura M, et al. Clinicopathological features and outcomes of diabetic kidney disease with extracapillary hypercellularity: a Japanese single-center experience. Clin Exp Nephrol. 2020;24:509–17.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–8.
Li AS, Saleh C, Denley H, Patel M, Brix SR. ANCA renal risk score predicts outcome in the Manchester cohort. Kidney Int. 2019;96:246–7.
Smith JR, Methven S, Stevens KI, Mackinnon B, Kidder D. Renal risk score performance in a cohort of Scottish patients with ANCA-associated glomerulonephritis. Kidney Int. 2019;96:1037.
Mejia-Vilet JM, Martin-Nares E, Cano-Verduzco ML, Perez-Arias AA, Sedano-Montoya MA, Hinojosa-Azaola A. Validation of a renal risk score in a cohort of ANCA-associated vasculitis patients with severe kidney damage. Clin Rheumatol. 2020;39:1935–43.
Villacorta J, Diaz-Crespo F, Guerrero C, Acevedo M, Cavero T, Fernandez-Juarez G. Long-term validation of the renal risk score for vasculitis in a southern European population. Clin Kidney J. 2020;14:220–5.
An XN, Wei ZN, Yao XY, Xu J, Qian WT, Pan XX, et al. Evaluating renal outcome of ANCA-associated renal vasculitis: comparative study of two histopathological scoring systems. Clin Exp Rheumatol. 2021;39(Supplement 129):39–45 (Epub ahead of print; PMID: 33337988).
Hilhorst M, van Paassen P, Tervaert JW, Limburg Renal Registry. Proteinase 3-ANCA vasculitis versus myeloperoxidase-ANCA Vasculitis. J Am Soc Nephrol. 2015;26:2314–27.
Muso E, Endo T, Itabashi M, Kakita H, Iwasaki Y, Tateishi Y, et al. Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol. 2013;17:659–62.
Togashi M, Komatsuda A, Nara M, Omokawa A, Okuyama S, Sawada K, et al. Validation of the 2010 histopathological classification of ANCA-associated glomerulonephritis in a Japanese single-center cohort. Mod Rheumatol. 2014;24:300–3.
Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, European Vasculitis Study Group (EUVAS), et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int. 2002;61:80–9.
de Joode AA, Sanders JS, Stegeman CA. Renal survival in proteinase 3 and myeloperoxidase ANCA-associated systemic vasculitis. Clin J Am Soc Nephrol. 2013;8:1709–17.
Quintana LF, Peréz NS, De Sousa E, Rodas LM, Griffiths MH, Solé M, Jayne D. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant. 2014;29:1764–9.
Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant. 2004;19:1403–11.
Hong Y, Shi P, Liu X, Yang L, Li K, Xu F, et al. Distinction between MPO-ANCA and PR3-ANCA-associated glomerulonephritis in Chinese patients: a retrospective single-center study. Clin Rheumatol. 2019;38:1665–73.
Bajema IM, Hagen EC, Hermans J, Noel LH, Waldherr R, Ferrario F, et al. Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int. 1999;56:1751–8.
Sada KE, Harigai M, Amano K, Atsumi T, Fujimoto S, Yuzawa Y, et al. Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody associated vasculitis in a nationwide, prospective, inception cohort study. Mod Rheumatol. 2016;26:730–7.
Acknowledgements
The authors thank all the doctors at our affiliated hospitals for referral of patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that no conflicts of interest exists.
Ethical approval
All the procedures were performed in accordance with the ethical standards of the institutional and/or national research committee at which the studies were conducted (IRB approval number 1830), as well as the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all the individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
About this article
Cite this article
Saito, M., Saito, A., Abe, F. et al. Evaluation of a newly proposed renal risk score for Japanese patients with ANCA-associated glomerulonephritis. Clin Exp Nephrol 26, 760–769 (2022). https://doi.org/10.1007/s10157-022-02217-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-022-02217-w